These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28255982)

  • 1. Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 2).
    Gion M; Trevisiol C; Rutjes AWS; Rainato G; Fabricio ASC
    Int J Biol Markers; 2017 Mar; 32(1):e1-e52. PubMed ID: 28255982
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 3).
    Gion M; Trevisiol C; Rutjes AWS; Rainato G; Fabricio ASC
    Int J Biol Markers; 2017 May; 32(2):e147-e181. PubMed ID: 28475208
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 1).
    Gion M; Trevisiol C; Rutjes AW; Rainato G; Fabricio AS
    Int J Biol Markers; 2016 Dec; 31(4):e332-e367. PubMed ID: 28025819
    [No Abstract]   [Full Text] [Related]  

  • 4. Erratum to: Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 1), (PART 2), (PART 3).
    Int J Biol Markers; 2017 Oct; 32(4):e478. PubMed ID: 29048700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice guidelines for tumor marker use in the clinic.
    Sturgeon C
    Clin Chem; 2002 Aug; 48(8):1151-9. PubMed ID: 12142367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for knowledge translation to improve tumor marker application.
    Gion M
    Int J Biol Markers; 2016 Dec; 31(4):e331. PubMed ID: 28025818
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating tumour cells and circulating endothelial cells as biomarkers in oncology.
    Strijbos MH
    Acta Clin Belg; 2011; 66(5):332-6. PubMed ID: 22145267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of the implementation of a protocol for the adequate and safe use of tumor markers].
    Mérida de la Torre FJ; Moreno Campoy EE; Martos Crespo F
    Med Clin (Barc); 2015 Dec; 145(12):526-8. PubMed ID: 26169333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conflicting clinical guidelines.
    Schmidt C
    J Natl Cancer Inst; 2013 Jan; 105(1):2-3. PubMed ID: 23257157
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic role of tumor markers.
    Mérida de la Torre FJ; Moreno Campoy EE
    Med Clin (Barc); 2019 Mar; 152(5):185-187. PubMed ID: 30502299
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy.
    Schlange T; Pantel K
    Pharmacogenomics; 2016 Feb; 17(3):183-6. PubMed ID: 26799583
    [No Abstract]   [Full Text] [Related]  

  • 12. Liquid Biopsies in Oncology and the Current Regulatory Landscape.
    Strotman LN; Millner LM; Valdes R; Linder MW
    Mol Diagn Ther; 2016 Oct; 20(5):429-36. PubMed ID: 27324559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness.
    Arioli D; Pipino M; Boldrini E; Amateis E; Cristani A; Ventura P; Romagnoli E; De Santis MC; Zeneroli ML
    Intern Emerg Med; 2007 Jun; 2(2):88-94. PubMed ID: 17622496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding next generation sequencing in oncology: A guide for oncologists.
    Moorcraft SY; Gonzalez D; Walker BA
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):463-74. PubMed ID: 26160606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of circulating biomarkers in early clinical trials in patients with cancer.
    D'Arcangelo M; Margetts J; Greystoke A
    Biomark Med; 2015; 9(10):1011-23. PubMed ID: 26441037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of tumor markers in serum. Pitfalls and good practice.
    Basuyau JP; Leroy M; Brunelle P
    Clin Chem Lab Med; 2001 Dec; 39(12):1227-33. PubMed ID: 11798082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When and how to use serum tumor markers in clinical practice.
    Markman M
    Cleve Clin J Med; 1997 Jan; 64(1):27-9. PubMed ID: 9014381
    [No Abstract]   [Full Text] [Related]  

  • 18. Grail to pour $1 billion into blood test to detect early cancer.
    Sheridan C
    Nat Biotechnol; 2017 Feb; 35(2):101-102. PubMed ID: 28178244
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomarkers, inflammation and cancer: where to go?
    Melichar B
    Clin Chem Lab Med; 2016 Dec; 54(12):1847-1852. PubMed ID: 27718488
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomarkers in the treatment of cancer: opportunities and pitfalls.
    Melichar B
    Clin Chem Lab Med; 2013 Jul; 51(7):1329-33. PubMed ID: 23729626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.